Key terms

About CERS

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CERS news

Apr 26 8:50am ET Analysts Are Bullish on These Healthcare Stocks: Cerus (CERS), MiMedx Group (MDXG) Apr 12 8:35am ET Cerus Corporation: Strong Buy Rating Amidst Growth and Path to Profitability Apr 12 8:24am ET Craig-Hallum starts Cerus at Buy, sees shares more than doubling Apr 12 7:19am ET Cerus initiated with a Buy at Craig-Hallum Mar 22 11:33am ET Biotech Alert: Searches spiking for these stocks today Mar 21 11:18am ET Biotech Alert: Searches spiking for these stocks today Mar 20 8:15pm ET Cathie Wood’s ARK Investment bought 193K shares of Cerus today Mar 19 8:08am ET Cerus announces ReCePI trial met primary efficacy endpoint Mar 18 8:17pm ET Cathie Wood’s ARK Investment bought 278K shares of Cerus today Mar 18 6:27am ET Cerus’s Strong Q4 Performance and Positive 2024 Outlook Prompt ‘Buy’ Rating Mar 13 8:06pm ET Cathie Wood’s ARK Investment bought 296K shares of Cerus today Mar 13 6:10am ET Analysts Offer Insights on Healthcare Companies: iCAD (ICAD), Mustang Bio (MBIO) and Cerus (CERS) Mar 07 1:00am ET Cerus Corporation’s New Share Price & Shareholder Rights Risk – A Cause for Worry? Mar 06 7:37am ET Stifel Nicolaus Keeps Their Buy Rating on Cerus (CERS) Mar 05 4:29pm ET Cerus affirms 2024 product revenue guidance Mar 05 4:03pm ET Cerus reports Q4 EPS (1c) , consensus (2c)

No recent press releases are available for CERS

CERS Financials

1-year income & revenue

Key terms

CERS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CERS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms